RBP4 variants are significantly associated with plasma RBP4 levels and hypertriglyceridemia risk in Chinese Hans

Journal of Lipid Research

Volumn 50, Issue 7, 2009, Pages 1479-1486

  Wu, Ying ^a   Li, Huaixing ^a   Loos, Ruth J F ^b   Qi, Qibin ^a   Hu, Frank B ^c   Liu, Yong ^a   Lin, Xu ^a  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Mendelian randomization; SNP

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CAUSAL ATTRIBUTION; CHINESE; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENOTYPE; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN VARIANT; QUANTITATIVE TRAIT; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; METABOLIC SYNDROME X; RANDOM ALLOCATION; RETINOL-BINDING PROTEINS, PLASMA; RISK FACTORS;

EID: 67650552639     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.P900014-JLR200     Document Type: Article

References (26)

1. von Eynatten,M., and P.M. Humpert. 2008. Retinol-binding protein-4 in experimental and clinical metabolic disease. Expert Rev. Mol. Diagn. 8: 289-299.
2. Yang, Q., T. E. Graham, N. Mody, F. Preitner, O. D. Peroni, J. M. Zabolotny, K. Kotani, L. Quadro, and B. B. Kahn. 2005. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 436: 356-362.
3. Graham, T. E., Q. Yang, M. Bluher, A. Hammarstedt, T. P. Ciaraldi, R. R. Henry, C. J. Wason, A. Oberbach, P. A. Jansson, U. Smith, et al. 2006. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med. 354: 2552-2563.
4. Munkhtulga, L., K. Nakayama, N. Utsumi, Y. Yanagisawa, T. Gotoh, T. Omi, M. Kumada, B. Erdenebulgan, K. Zolzaya, T. Lkhagvasuren, et al. 2007. Identification of a regulatory SNP in the retinol binding protein 4 gene associated with type 2 diabetes in Mongolia. Hum. Genet. 120: 879-888.
5. vanHoek,M., A. Dehghan,M. C. Zillikens, A.Hofman, J. C. Witteman, and E. J. Sijbrands. 2008. An RBP4 promoter polymorphism increases risk of type 2 diabetes. Diabetologia. 51: 1423-1428.
6. Craig, R. L., W. S. Chu, and S. C. Elbein. 2007. Retinol binding protein 4 as a candidate gene for type 2 diabetes and prediabetic intermediate traits. Mol. Genet. Metab. 90: 338-344.
7. Kovacs, P., M. Geyer, J. Berndt, N. Kloting, T. E. Graham, Y. Bottcher, B. Enigk, A. Tonjes, D. Schleinitz, M. R. Schon, et al. 2007. Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression. Diabetes. 56: 3095-3100.
8. Janke, J., S. Engeli, M. Boschmann, F. Adams, J. Bohnke, F. C. Luft, A. M. Sharma, and J. Jordan. 2006. Retinol-binding protein 4 in human obesity. Diabetes. 55: 2805-2810.
9. von Eynatten, M., P. M. Lepper, D. Liu, K. Lang, M. Baumann, P. P. Nawroth, A. Bierhaus, K. A. Dugi, U. Heemann, B. Allolio, et al. 2007. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia. 50: 1930-1937.
10. Takashima, N., H. Tomoike, and N. Iwai. 2006. Retinol-binding protein 4 and insulin resistance. N. Engl. J. Med. 355: 1392 (author reply 1394-1395).
11. Erikstrup, C., O. H. Mortensen, and B. K. Pedersen. 2006. Retinol-binding protein 4 and insulin resistance. N. Engl. J. Med. 355: 1393-1394 (author reply 1394-1395).
12. Broch, M., J. Vendrell, W. Ricart, C. Richart, and J. M. Fernandez-Real. 2007. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and non-obese subjects. Diabetes Care. 30: 1802-1806.
13. Promintzer, M., M. Krebs, J. Todoric, A. Luger, M. G. Bischof, P. Nowotny, O. Wagner, H. Esterbauer, and C. Anderwald. 2007. Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J. Clin. Endocrinol. Metab. 92: 4306-4312.
14. Takebayashi, K., M. Suetsugu, S. Wakabayashi, Y. Aso, and T. Inukai. 2007. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J. Clin. Endocrinol. Metab. 92: 2712-2719.
15. Lee, D. C., J. W. Lee, and J. A. Im. 2007. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism. 56: 327-331.
16. Hutchison, S. K., C. Harrison, N. Stepto, C. Meyer, and H. J. Teede. 2008. Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome. Diabetes Care. 31: 1427-1432.
17. Zugaro, A., C. Pandolfi, A. Barbonetti, M. R. Vassallo, A. D'Angeli, S. Necozione, M. S. Colangeli, S. Francavilla, and F. Francavilla. 2007. Retinol binding protein 4, low birth weight-related insulin resistance and hormonal contraception. Endocrine. 32: 166-169.
18. Aeberli, I., R. Biebinger, R. Lehmann, D. L'Allemand, G. A. Spinas, and M. B. Zimmermann. 2007. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J. Clin. Endocrinol. Metab. 92: 4359-4365.
19. Sandhu, M. S., S. L. Debenham, I. Barroso, and R. J. Loos. 2008. Mendelian randomisation studies of type 2 diabetes: future prospects. Diabetologia. 51: 211-213.
20. Sheehan, N. A., V. Didelez, P. R. Burton, and M. D. Tobin. 2008. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med. 5: e177.
21. Qi, Q., Z. Yu, X. Ye, F. Zhao, P. Huang, F. B. Hu, O. H. Franco, J. Wang, H. Li, Y. Liu, et al. 2007. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J. Clin. Endocrinol. Metab. 92: 4827-4834.
22. Ye, X., Z. Yu, H. Li, O. H. Franco, Y. Liu, and X. Lin. 2007. Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J. Am. Coll. Cardiol. 49: 1798-1805.
23. Tobin, M. D., N. A. Sheehan, K. J. Scurrah, and P. R. Burton. 2005. Adjusting for treatment effects in studies of quantitative traits: anti-hypertensive therapy and systolic blood pressure. Stat. Med. 24: 2911-2935.
24. Davey Smith, G., and S. Ebrahim. 2003. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol. 32: 1-22.
25. Smith, G. D., D. A. Lawlor, R. Harbord, N. Timpson, I. Day, and S. Ebrahim. 2007. Clustered environments and randomized genes: a fundamental distinction between conventional and genetic epidemiology. PLoS Med. 4: e352.
26. Nitsch, D., M. Molokhia, L. Smeeth, B. L. DeStavola, J. C. Whittaker, and D. A. Leon. 2006. Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials. Am. J. Epidemiol. 163: 397-403.